Isabelle Fournier and her team are out to change surgical oncology.
“Better surgery is associated with better prognosis and higher survival,” said Fournier, a professor at the University of Lille and co-director of a proteomics center of INSERM, the French national institute of health. Her laboratory has worked for several years on a device they call the SpiderMass that will enable surgeons to look for markers of cancer in a living patient’s tissue, during an operation. In an article in Molecular & Cellular Proteomics, the team reports on an important step toward finding protein biomarkers during surgery.
Surgery to remove a primary tumor involves a wait. After the tumor and some healthy surrounding tissue are removed, the surgical team pauses while a pathologist checks the tissue margins under a microscope. Although this process is important for preventing recurrence of the cancer, it can add up to 45 risky minutes under anesthesia.
With the new device, Fournier said, “We think that it is possible to open the way to in vivo real-time proteomics,” which could help surgeons find stray cancer cells faster, perhaps even as they make incisions.
Fournier’s device uses mass spectrometry, which measures the mass of molecules from complex mixtures. But turning an in vivo tissue sample into gas phase ions for measurements can be a challenge. Until now, no one knew how to extract ions from living tissues without doing harm.
So Fournier’s team got creative. Riffing on MALDI, an ionization strategy that uses a carrier molecule mixed with the analyte of interest, they decided to use the water that makes up a majority of human tissue as a carrier to produce a water-assisted laser desorption/ionization, or WALDI. If they could excite the water in a tiny area, it should vaporize, taking ionized organic molecules with it.
“It was an idea at the beginning, and many people thought that it would not work,” Fourier said. “Finally, we have it working beautifully.”
The team built a pulsed laser excitation device tuned to heat water precisely by causing vibration in the oxygen-hydrogen bond. In a 2016 paper, they described using this laser to ionize the outermost layer of tissue, penetrating less than one-twentieth of a millimeter. The human volunteers reported a slight tingling sensation. But the ions that appeared were mostly small molecules and lipids, which are more apt than proteins to adopt a negative charge. The team hoped to measure proteins as well.
In this new paper, Fournier and colleagues report that they have cracked the protein puzzle. By using a more sensitive mass spectrometer and looking for positively instead of negatively charged ions, they found peaks representing purified proteins they had introduced into a cow liver sample. Now that they know the proteins are detectable, the next step will be finding ways to amplify the protein signal over more abundant lipids and metabolites.
In the meantime, the device is already in use for four-legged patients. Fournier’s lab has worked with the veterinary biotech company Oncovet Clinical Research to run a pilot trial, comparing biopsies from pet dogs with sarcoma to healthy tissues. The team developed a lipidomics- and metabolomics-based classification system to robustly identify healthy, necrotic and cancerous tissues. Soon, they will introduce a prototype into a veterinary operating room. If it is successful there, Fournier said, she hopes to reach human clinics, improving tumor removal surgery to give patients better health outcomes.
The Latest on: Proteomics
via Google News
The Latest on: Proteomics
- Seer Debuts with Proprietary Proteomics Platform to Enable Early Detection of Cancer and Neurological Diseases on December 17, 2018 at 4:00 am
Seer, Inc., launched today to capture and translate molecular insights from the proteome to enable early detection of cancer and neurological diseases and drive earlier treatment to improve patient ou... […]
- Genomics and Proteomics Reagents, Research Kits and Analytical Instruments Market Is Projected to Expand at a CAGR of 12.1% from 2013 to 2019 on December 14, 2018 at 7:56 pm
Albany, NY -- (SBWIRE) -- 12/14/2018 -- The global genomics and proteomics reagents, research kits and analytical instruments market is highly fragmented, in terms of vendor landscape, states a new re... […]
- Quantitative proteomics using SILAC-MS identifies N-acetylcysteine-solution-triggered reversal response of renal cell carcinoma cell lines. on December 11, 2018 at 11:00 pm
N-acetylcysteine (NAC), a precursor for glutathione (GSH), causes permeable antioxidation protecting normal cells and disrupting cancer cells. In the present study, we found that a NAC-based medium ca... […]
- Proteomics Market is Estimated to Grow at a Substantial CAGR of 11.50% by 2022: Radiant Insights, Inc. on December 11, 2018 at 3:45 am
SAN FRANCISCO, December 11, 2018 /PRNewswire via COMTEX/ -- SAN FRANCISCO, December 11, 2018 /PRNewswire/ -- Global Proteomics Market is estimated to grow at a substantial CAGR of 11.50% during the pe... […]
- Proteomics: cracking the molecular mystery of diseases and therapeutics on December 10, 2018 at 3:53 am
In the wake of the human genome project, molecular biology and genetic technologies are tremendously integrating into biomedical research. Currently, PCR, qPCR, and sequencing are key tools in the cli... […]
- A Proteomics Dive into Cause of Frontotemporal Dementia on December 6, 2018 at 3:57 pm
If DNA makes RNA makes protein, then genomic variants make RNA make protein … make disease. While scientists have found polymorphisms that associate with various forms of frontotemporal dementia, deci... […]
- Lab Technician Proteomics on December 6, 2018 at 8:16 am
In the Biomolecular Mass Spectrometry and Proteomics group of Utrecht University, you will work in a great and inspiring research environment with professional colleagues active in various fields of a... […]
- Global Proteomics Market Opportunities to 2023 - Technological Advancements: A Key Driver - ResearchAndMarkets.com on December 3, 2018 at 9:27 pm
DUBLIN--(BUSINESS WIRE)--The "Global Proteomics Market - Forecasts from 2018 to 2023" report has been added to ResearchAndMarkets.com's offering. Global proteomics market is expected to grow at a ... […]
- Integrated proximal proteomics reveals IRS2 as a determinant of cell survival in ALK-driven neuroblastoma on November 20, 2018 at 11:38 am
1 Proteomics Program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark. 2 Department o... […]
via Bing News